VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Alibaba Group Holding Limited vs Bristol-Myers Squibb Company
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Alibaba Group Holding Limited
9988.HK · The Stock Exchange of Hong Kong Limited
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Alibaba Group Holding Limited's moat claims, evidence, and risks.
View 9988.HK analysisBristol-Myers Squibb Company
BMY · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Bristol-Myers Squibb Company's moat claims, evidence, and risks.
View BMY analysisComparison highlights
- Moat score: both at 56 / 100.
- Segment focus: Alibaba Group Holding Limited has 7 segments (41% in Taobao and Tmall Group); Bristol-Myers Squibb Company has 5 segments (27.6% in Eliquis franchise (apixaban)).
- Moat breadth: Alibaba Group Holding Limited has 6 moat types across 3 domains; Bristol-Myers Squibb Company has 4 across 3.
Primary market context
Alibaba Group Holding Limited
Taobao and Tmall Group
China online retail marketplaces & merchant services (Taobao, Tmall, 1688)
China
Consumers and merchants/brands
Marketplace + advertising/merchant services
41%
Bristol-Myers Squibb Company
Eliquis franchise (apixaban)
Direct oral anticoagulants (DOACs) for stroke prevention in NVAF and treatment/prevention of DVT/PE
Global
Payers, PBMs, hospitals, clinics, pharmacies
Branded drug manufacturer (co-commercialization alliance)
27.6%
Side-by-side metrics
Moat coverage
Shared moat types
Alibaba Group Holding Limited strengths
Bristol-Myers Squibb Company strengths
Segment mix
Alibaba Group Holding Limited segments
Full profile >Taobao and Tmall Group
Oligopoly
Alibaba International Digital Commerce Group
Competitive
Cloud Intelligence Group (Alibaba Cloud)
Oligopoly
Cainiao Smart Logistics Network Limited
Competitive
Local Services Group
Oligopoly
Digital Media and Entertainment Group
Competitive
All Others
Competitive
Bristol-Myers Squibb Company segments
Full profile >Eliquis franchise (apixaban)
Oligopoly
Immuno-oncology checkpoint inhibitors (Opdivo/Yervoy/Opdualag)
Oligopoly
Hematology (Revlimid/Pomalyst/Reblozyl)
Competitive
Immunology (Orencia/Sotyktu)
Competitive
Other specialty & emerging products (CAR-T, cardiomyopathy, neuroscience, and mature brands)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.